Cambridge Nutritional Sciences Plc Adjusts Valuation Amid Declining Sales and Financial Metrics
Cambridge Nutritional Sciences Plc has experienced a recent adjustment in its evaluation, influenced by changes in financial metrics and market position. Key indicators, including a P/E ratio of 8 and a return on equity of 2.46%, highlight the company's financial health amid a decline in net sales.
Cambridge Nutritional Sciences Plc has recently undergone an adjustment in evaluation, reflecting changes in its financial metrics and market position. The company's valuation score has been revised, indicating a shift in its perceived attractiveness within the Pharmaceuticals & Biotechnology sector.Key financial indicators reveal a P/E ratio of 8, which suggests a specific valuation context compared to industry standards. The Price to Book Value stands at 0.80, while the EV to EBIT is reported at -3.17, and the EV to EBITDA is at 3.17. These metrics provide insight into the company's financial health and operational efficiency.
Additionally, the company's return on equity (ROE) is noted at 2.46%, which, when considered alongside its PEG ratio of 0.07, points to a complex valuation landscape. The recent quarter ending September 2024 saw a decline in net sales by 16.21%, contributing to the overall assessment of the company's performance.
Overall, the adjustment in evaluation for Cambridge Nutritional Sciences Plc reflects a nuanced understanding of its current financial standing and market dynamics.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Most Read
